Hemostasis Today

May, 2026
May 2026
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Richard Buka: Exploring the COBRRA Trial in the Latest Episode of Don’t Just Read the Abstract
Mar 18, 2026, 16:34

Richard Buka: Exploring the COBRRA Trial in the Latest Episode of Don’t Just Read the Abstract

Richard Buka, Academic Clinical Lecturer at University of Birmingham, shared a post on LinkedIn about a recent article by Lana A. Castellucci  et al. published in NEJM:

Pip Nicolson and I have just released the latest episode of Don’t Just Read the Abstract.

In it, we discuss the COBRRA trial: Apixaban vs Rivaroxaban for Acute Venous Thromboembolism (Castellucci et al. 2026, NEJM).

Check it out – and let us know if we missed something important!”

Title: Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism

Authors: Lana A. Castellucci, Vivien M. Chen, Michael J. Kovacs, Alejandro Lazo-Langner, Peter Greenstreet, Susan Kahn, Benoit Côté, Sam Schulman, Kerstin de Wit, James Douketis, Deepa Suryanarayan, Tony Wan, Erik Yeo, Genevieve Le Templier, Huyen A. Tran, Abbey Willcox, Helen J. Crowther, Ritam Prasad, Sudeep Shivakumar, Etimbuk Umana, Fionnuala Ni Ainle, Tobias Tritschler, Stefano Barco, Jean-Philippe Galanaud, Marc Blondon, Lisa Baumann Kreuziger, Susan Solymoss, Clive Kearon, Erin Thomas, Tim Ramsay, Gregoire Le Gal, Marc Rodger

Read the Full Article on NEJM

Richard Buka: Exploring the COBRRA Trial in the Latest Episode of Don’t Just Read the Abstract

Stay updated with Hemostasis Today.